US court orders Eli Lilly to pay royalties on diabetes drugs

Eli Lilly owes an Arizonan company royalties from insulin product sales, a US court has ruled, as reported by news organization Endpoint News. A trial is now likely.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app